IGC Pharma, Inc. (IGC)

ASE – Real Time Price. Currency in USD

0.30

-0.01 (-2.15%)

At close: May 12, 2026, 4:00 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2024

2023

2022

2021

Total Revenue

911K

397K

Cost of goods sold

-1M

-830K

Gross Profit

52K

170K

-158K

-433K

Operating expenses (excl. COGS)

-7M

-10M

-11M

-15M

Operating Income

-7M

-10M

-12M

-15M

Non-operating income, total

325K

-3M

65K

412K

Pretax income

-7M

-13M

-12M

-15M

Equity in earnings

Taxes

Non-controlling/minority interest

After tax other income/expense

Net income before discontinued operations

-7M

-13M

-12M

-15M

IGC Pharma, Inc. (IGC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

IGC Pharma, Inc. (IGC)

Income Statement (Annual)

Income Statement (Annual)

Search stocks

IGC Pharma, Inc. (IGC)

Get all premium features to the best stock analysis tool

Finranks

Company

Contact us

Follow us

IGC Pharma, Inc. (IGC)

Income Statement (Annual)

Income Statement (Annual)